Comparative Study of Conventional 1.5 and 3.0T MR Images With Synthetically Reconstructed MR Images
NCT ID: NCT02596854
Last Updated: 2018-06-18
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
117 participants
INTERVENTIONAL
2015-11-30
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Study of Conventional MR Images With Synthetically Reconstructed MR Images of the Brain
NCT05425927
Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2
NCT02556177
Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems
NCT07296263
Infiltration of Gadolinium Injection in Brain MR Scans Using Artificial Intelligence
NCT05235646
Advanced MRI Applications for Mild Traumatic Brain Injury
NCT02070588
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study consists of three parts:
1. Clinical MR acquisition,
2. synthetic MR post-processing at a GE facility, and
3. blinded image evaluation (BIE) of conventional and synthetic images for each subject.
The study will enroll eligible adult subjects with clinical indications for brain MRI that meet applicable site MR safety criteria and are not pregnant. The study consists of one visit, the subject's MRI scan, without additional follow-up. Results are expected to be representative of expected clinical usage of synthetic MAGiC MR technology in clinical practice.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neurological MRI
Images acquired for post processing with synthetic software. This is a crossover design where all subjects receive the same imaging scan, and comparison is done between the raw conventional scan and post-processed images using the research software.
Neurological MRI
Neurological MRI image collection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neurological MRI
Neurological MRI image collection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Be an adult 18 years of age or older;
2. Have clinical indication for MRI of the brain according to the site standard of care;
3. If female of childbearing potential (not surgically sterile or post-menopausal), be determined non-pregnant by a medically qualified investigator or demonstrated non-pregnant by negative urine pregnancy test;
4. Be able to hear and understand instructions without assistive devices;
5. Have necessary mental capacity to understand instructions be able to comply with protocol requirements;
6. Are able and willing to provide written informed consent by signing the informed consent form (ICF).
Exclusion Criteria
1. Were previously enrolled in this evaluation;
2. Have metallic/conductive or electrically/magnetically active implants or attached medical devices (except for dental devices/fillings, surgical clips, and surgical staples) that could be unsafe for MRI;
3. Have contraindication(s) to MRI scanning per the routine MR Safety Screening policy of the investigational site;
4. Have severe trauma or pre-existing pathology that is expected to interfere with normal conduct of MR scanning or complete scanning of the brain;
5. Have medical condition(s) such as those requiring urgent medical care that, in the opinion of a physician Investigator, would prevent safe participation in the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ICON plc
INDUSTRY
GE Healthcare
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Maryland Medical Center
Baltimore, Maryland, United States
Advanced Radiology Services, PC/Spectrum Health
Grand Rapids, Michigan, United States
The Mount Sinai Hospital
New York, New York, United States
Cornell University
New York, New York, United States
Manhattan Diagnostic Radiology (RadNet)
New York, New York, United States
University of Wisconsin-Madison
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
114-2015-GES-0056
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.